The report “Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlook (2016-2020)” analyzes the. For more mail: vikas@konceptanalytics.com

1. Industry Research by Koncept Analytics
1
November 2016
Global Erythropoietin (EPO)
Market with Focus on Asia:
Industry Analysis & Outlook
-----------------------------------------
(2016-2020)
Global Erythropoietin (EPO) Market with Focus on
Asia: Industry Analysis & Outlook (2016-2020)

2. Executive Summary
2
Global Erythropoietin (EPO) Market with Focus on
Asia: Industry Analysis & Outlook (2016-2020)
Erythropoietin is a substance produced by the kidney that leads to the formation of red blood cells in the
bone marrow. It is a glycoprotein hormone which regulates erythropoiesis (Red Blood Cell production). For
erythrocyte precursors present in the bone marrow, EPO acts as a cytokine. Commonly referred to as
hematopoietin or hemopoietin, erythropoietin is also known to have other biological functions, such as
involvement in the wound healing cycle and brain’s response to neuronal injury. People suffering from End
Stage Renal Disease (ESRD), HIV or undergoing chemotherapy are not able to produce enough EPO on their
own and thus, are administered with synthetic or recombinant erythropoietin which has the similar sequence
of amino acids. Recombinant erythropoietin is a kind of therapeutic agent devised using DNA technology.
On the bases of their molecular structure, EPO drugs can be divided into five categories: epoetin-alfa,
epoetin-beta, epoetin-omega, epoetin-delta and darbepoetin-alfa. Among these epoetin-alfa and
darbepoetin-alfa are most commonly prescribed EPO drugs.
The global EPO drugs market is expected to experience negative growth rate, primarily due to expiry of
patents of two most common EPO drugs, epoetin-alfa and darbepoetin-alfa, allowing the entry of biosimilars;
posing a serious threat to EPO drugs market. However, the Asia-Pacific region is expected to experience
boom period majorly due to improving disposable income and better government medical reimbursement
policies.
The report “Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlook (2016-
2020)” analyzes the development of this market, with focus on the US and Asia-Pacific markets. The major
trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The
four major players: Johnson & Johnson, Amgen, Roche and Teva Pharmaceutical Industries Limited are being
profiled along with their key financials and strategies for growth. The report contains a comprehensive
analysis of the global EPO market along with the study of the regional markets.

3. Globally rising incidences of cancer, End Stage Renal Disease (ESRD) and other chronic ailments would expectedly drive
growth of the global EPO market. However, the expiry of patents of epoetin-alfa in year 2015 and darbepoetin-alfa in late
2016 will have a negative impact on the overall market growth.
3
• The global EPO market reached US$... billion by the end
of year 2015, recording a mild decline of ….% from
previous years revenue of US$... billion.
• In 2016, the global EPO market will reach US$... billion
and is expected to fall to US$... billion mark by 2020,
declining at a CAGR of …%, spanning from 2016 to
2020.
• In year 2015, the US held …% share of the global EPO
drug market followed by Asia-Pacific with merely …%
share. However, by the end of year 2020, the market
share of the US will fall to …% and Asia-Pacific will rise
to …%.
Global EPO Drug Market by Value – Forecast (2016-2020)
Global EPO Drug Market by Value (2011-2015)
Global EPO Drug Market by Region (2015/2020)
Global Erythropoietin (EPO) Market with Focus on
Asia: Industry Analysis & Outlook (2016-2020)
20152020

4. The Asia-Pacific region is expected to experience boom period majorly due to improving disposable income and better
government medical reimbursement policies.
4
• In 2015, the market was recorded at US$... billion and
is expected to fall to nearly US$... billion by the end of
2020, declining at a CAGR of …%, spanning from 2015
to 2020.
• In 2015, the China EPO market was recorded at US$...
billion, compared to US$... billion in 2014, representing
an annual increment of nearly …% from the previous
year.
• In 2015, the EPO market value of Malaysia was
recorded at US$... million and is further expected to
accelerate at an impressive CAGR of …%, spanning from
2015 to 2020 and reach US$... million by the end of
2020.
China EPO Drug Market by Value (2011-2015)
The US EPO Drug Market by Value – Forecast (2015-2020)
Malaysia EPO Drug Market by Value – Forecast (2015-2020)
Global Erythropoietin (EPO) Market with Focus on
Asia: Industry Analysis & Outlook (2016-2020)

5. Koncept Analytics
CS-36, First Floor, Ansal Plaza
Vaishali, Ghaziabad,
U.P. – 201010
T: +91-120-4130959
M: +91-9811715635
vikas@konceptanalytics.com
Contact Us:
www.konceptanalytics.com
This is a licensed product of Koncept Analytics. You cannot reproduce, publish, distribute, publicly display, sell or create
other works from this report or use them in any way for commercial purpose without our prior permission. Further, you
cannot copy this material, by any means (including electronic copies), for distribution to others unless you have purchased
the corporate license of this report.
We believe the sources are reliable, but Koncept Analytics does not warranty the accuracy or completeness of the data. The
data presented in the report is updated at the publication date but is subject to change at subsequent releases. All possible
efforts have been made to ensure accuracy of data. However, investors should not completely rely on the information given
in this report and must make decisions based on their own investment strategy, risk management and capital adequacy.
5
Disclaimer
Global Erythropoietin (EPO) Market with Focus on
Asia: Industry Analysis & Outlook (2016-2020)